JPH0358326B2 - - Google Patents
Info
- Publication number
- JPH0358326B2 JPH0358326B2 JP60050853A JP5085385A JPH0358326B2 JP H0358326 B2 JPH0358326 B2 JP H0358326B2 JP 60050853 A JP60050853 A JP 60050853A JP 5085385 A JP5085385 A JP 5085385A JP H0358326 B2 JPH0358326 B2 JP H0358326B2
- Authority
- JP
- Japan
- Prior art keywords
- hydroquinone
- vitamin
- tocopherol
- glucose
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 23
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 11
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- NPPRLEYXLWDOKT-WYRLRVFGSA-N benzene-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC1=CC=C(O)C=C1.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O NPPRLEYXLWDOKT-WYRLRVFGSA-N 0.000 claims description 8
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 12
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 238000002845 discoloration Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 229960000271 arbutin Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- -1 hydroquinone glycoside Chemical class 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229940066595 beta tocopherol Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000007680 β-tocopherol Nutrition 0.000 description 2
- 239000011590 β-tocopherol Substances 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
[産業上の利用分野]
本発明はハイドロキノン−β−D−グルコース
とビタミンE類の一種又は二種以上とを含有して
なる保存安定性に優れた組成物に関し、化粧品、
医薬品、医薬部外品等の分野に有用な皮膚外用剤
を提供することを目的とする。
[従来の技術]
皮膚のしみなどの発生機序については不明な点
もあるが、一般には、ホルモンの異常や日光から
の紫外線の刺激が原因となつてメラニン色素が形
成され、これが皮膚内に異常沈着するものと考え
られている。
このようなしみの治療法にはメラニンの生成を
抑制する物質、たとえばビタミンC、グルタチオ
ン、システインあるいはハイドロキノンなどを配
合した内服や外用製剤が用いられている。
しかしながら、ビタミンC、グルタチオン、シ
ステインは安定性に問題があつたり、異臭が強か
つたりして製剤化が難しい。また、これらは効果
の発現がきわめて緩慢であるという欠点も有して
いる。また、ハイドロキノンは効果は一応認めら
れているものの、感作性があり、一般には使用が
制限されている。
本発明者らは、美白作用を有する物質について
長年の間検討を続けてきたが、特定のハイドロキ
ノンの配糖体が優れた美白作用を有し、安定性、
安全性も良好であることを見いだし、さきに特許
出願を行つた(特願昭58−164815号)。
[発明が解決しようとする問題点]
本発明者らが、その後検討を続けた結果、上記
ハイドロキノンの配糖体は苛酷な条件下で長期に
保存した場合には次第に変色を起こすことが判明
した。化粧品や医薬品などの基剤中に配合した場
合には、その傾向が強い。
本発明者らは上記事情に鑑み、これらハイドロ
キノンの配糖体を安定に系中に配合することを目
的に検討を重ねた結果、ビタミンE類が優れた効
果を発揮することを見いだし、本発明を完成する
に至つた。
[問題点を解決するための手段]
すなわち、本発明はハイドロキノン−β−D−
グルコースと、ハイドロキノン−β−D−グルコ
ース1重量部に対して、0.001〜1重量部のビタ
ミンE類を含有することを特徴とする皮膚外用剤
を提供するものである。
以下、本発明について詳述する。
本発明で用いられるハイドロキノン−β−D−
グルコースは、一般名をアルブチンといい、ハイ
ドロキノンにD−グルコースがβ結合したもので
ある。
ハイドロキノン−β−D−グルコースの配合量
は、皮膚外用剤全量中の0.1〜30重量%、好まし
くは6〜20重量%であり、また6重量%以上の配
合においてビタミンE類の添加効果が顕著であ
る。
本発明の、もう一方の必須構成成分はビタミン
E類である。具体例を挙げるならば、α−トコフ
エロール、β−トコフエロール、γ−トコフエロ
ール、δ−トコフエロール、酢酸トコフエロー
ル、ニコチン酸トコフエロールなどが例示され
る。本発明においては、これらの中から任意の一
種又は二種以上が選ばれて用いられる。これらの
ビタミンE類は天然由来でも合成品でも構わな
い。天然由来のビタミンE(d−α−トコフエロ
ール)を用いる場合は粗ビタミンEでも精製品で
もよいが、トコフエロールとして下記配合量の範
囲内であることが必要なので、トコフエロール含
量が高いことが望ましい。また、トコフエロール
以外に、たとえば、トリグリセライド、レシチ
ン、ビタミンK類、ビタミンA類、ユビキノンな
どが含まれていても構わない。
配合量は、皮膚外用剤全量中の0.01〜2重量%
程度、好ましくは0.05〜0.2重量%であり、ハイ
ドロキノン−β−D−グルコース1重量部に対し
て0.001〜1重量部で顕著な効果が発揮される。
ハイドロキノン−β−D−グルコースとビタミ
ンE類とを配合できる皮膚外用剤は、通常の皮膚
外用剤、たとえば、水溶液系、可溶化系、乳化
系、粉末分散系、水−油2層系、水−油−粉末3
層系などの広い範囲の基剤であり、用途も化粧
水、乳液、クリーム、パツクなどの基礎化粧料、
口紅、フアンデーシヨンなどのメーキヤツプ化粧
料、シヤンプー、リンス、ヘアトニツクなどの頭
髪化粧料などの化粧料のほか、医薬品、医薬部外
品など多岐にわたる。
本発明の皮膚外用剤には必要に応じて、本発明
の効果を損なわない範囲で、保湿剤、増粘剤、油
分、防腐剤、乳化剤、酸化防止剤、金属イオン封
鎖剤、紫外線吸収剤、粉末、薬剤、色剤、香料な
どを配合できる。
[発明の効果]
本発明の皮膚外用剤は美白剤として有用なハイ
ドロキノン−β−D−グルコースを含有し、かつ
経日の変色もない安定性良好な皮膚外用剤であ
る。
[実施例]
次に実施例によつて本発明をさらに詳細に説明
する。配合量は重量%である。
実施例1〜3、比較例1
[Industrial Field of Application] The present invention relates to a composition with excellent storage stability containing hydroquinone-β-D-glucose and one or more kinds of vitamin E, and relates to a composition for use in cosmetics,
The aim is to provide external skin preparations that are useful in the fields of pharmaceuticals and quasi-drugs. [Conventional technology] Although there are some points that are unclear about the mechanism by which skin spots occur, in general, melanin pigments are formed due to hormonal abnormalities or stimulation of ultraviolet rays from sunlight, and this is caused by the formation of melanin within the skin. It is thought that it is abnormally deposited. To treat such age spots, oral or external preparations containing substances that inhibit melanin production, such as vitamin C, glutathione, cysteine, or hydroquinone, are used. However, vitamin C, glutathione, and cysteine have problems with stability and have strong off-odors, making it difficult to formulate them into formulations. They also have the disadvantage that the onset of their effects is extremely slow. Furthermore, although hydroquinone has been shown to be effective, its use is generally restricted due to its sensitizing properties. The present inventors have been studying substances with whitening effects for many years, and found that a specific hydroquinone glycoside has an excellent whitening effect, has a high stability,
They found that the product was safe and immediately filed a patent application (Japanese Patent Application No. 164815-1981). [Problems to be Solved by the Invention] As a result of subsequent studies by the present inventors, it was found that the above-mentioned hydroquinone glycoside gradually changes color when stored for a long period of time under harsh conditions. . This tendency is strong when it is blended into the base of cosmetics, pharmaceuticals, etc. In view of the above circumstances, the present inventors conducted repeated studies with the aim of stably incorporating these hydroquinone glycosides into the system, and as a result, they discovered that vitamin E exhibits excellent effects, and the present invention I was able to complete it. [Means for solving the problems] That is, the present invention provides hydroquinone-β-D-
The present invention provides an external skin preparation characterized by containing 0.001 to 1 part by weight of vitamin E based on 1 part by weight of glucose and hydroquinone-β-D-glucose. The present invention will be explained in detail below. Hydroquinone-β-D- used in the present invention
Glucose, whose common name is arbutin, is a product in which D-glucose is β-bonded to hydroquinone. The blending amount of hydroquinone-β-D-glucose is 0.1 to 30% by weight, preferably 6 to 20% by weight of the total amount of the skin external preparation, and the effect of adding vitamin E is remarkable when it is blended at 6% by weight or more. It is. Another essential component of the present invention is vitamin E. Specific examples include α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol, tocopherol acetate, and tocopherol nicotinate. In the present invention, one or more of these may be selected and used. These vitamin E types may be of natural origin or synthetic products. When naturally-derived vitamin E (d-α-tocopherol) is used, either crude vitamin E or a purified product may be used, but the tocopherol content must be within the following range, so it is desirable to have a high tocopherol content. In addition to tocopherols, for example, triglycerides, lecithin, vitamins K, vitamins A, ubiquinone, and the like may be contained. The blending amount is 0.01 to 2% by weight of the total amount of the skin external preparation.
The amount is preferably 0.05 to 0.2% by weight, and a remarkable effect is exhibited at 0.001 to 1 part by weight per 1 part by weight of hydroquinone-β-D-glucose. External skin preparations that can contain hydroquinone-β-D-glucose and vitamin E include the usual external skin preparations, such as aqueous solutions, solubilized systems, emulsified systems, powder dispersion systems, water-oil two-layer systems, and water-oil systems. -Oil-Powder 3
It is a wide range of bases such as layered products, and can be used in basic cosmetics such as lotions, milky lotions, creams, and packs.
In addition to cosmetics such as makeup cosmetics such as lipsticks and foundations, and hair cosmetics such as shampoos, conditioners, and hair tonics, our products range from pharmaceuticals to quasi-drugs. The skin external preparation of the present invention may contain, as necessary, a humectant, a thickener, an oil, a preservative, an emulsifier, an antioxidant, a sequestering agent, an ultraviolet absorber, and the like, within a range that does not impair the effects of the present invention. Powders, drugs, colorants, fragrances, etc. can be added. [Effects of the Invention] The external skin preparation of the present invention contains hydroquinone-β-D-glucose, which is useful as a whitening agent, and has good stability without discoloration over time. [Example] Next, the present invention will be explained in more detail with reference to Examples. The blending amount is in weight%. Examples 1 to 3, Comparative Example 1
【表】
表−1において、基剤は下記の化粧水、変色度
合は50℃1カ月保存後のものを下記の基準で判定
した結果である。
(基剤)
エタノール 13.0
1,3−ブチレングリコール 10.0
POE(ポリオキシエチレン、以下同じ、15モル)
オレイルエーテル 1.0
エチルパラベン 0.1
香 料 0.05
精製水 残余
(変色度合)
◎ 変色が全くない
○ やや変色した
△ かなり変色した
× 変色が著しい
実施例 4
ナイトクリーム
A セタノール 4.0
ワセリン 7.0
スクワラン 21.0
ステアリン酸モノグリセライド 2.2
POE(20)ソルビタンモノステアレート 2.8
イソプロピルミリステート 6.0
β−トコフエロール 1.0
エチルパラベン 0.3
香 料 0.2
B プロピレングリコール 10.0
1,3−ブチレングリコール 5.0
アルブチン 1.0
精製水 残余
(製法)Aに属する油相部の成分とBに属する
水相部の成分とをそれぞれ別々に加熱溶解し、
油相部を水相部中に混合して乳化し、室温まで
冷却してクリームを得た。
実施例 5
フアンデーシヨン
A セタノール 3.5
脱臭ラノリン 4.0
ホホバ油 5.0
ワセリン 2.0
スクワラン 6.0
ステアリン酸モノグリセライド 2.5
酢酸トコフエロール 0.05
POE(60)硬化ヒマシ油 1.5
POE(25)セチルエーテル 1.0
香 料 0.2
B グリセリン 3.0
プロピレングリコール 8.0
調合粉末 12.0
アルブチン 0.5
精製水 残余
(製法)Aに属する油相部の成分を加熱溶解す
る。これとは別に、調合粉末を除くBに属する
水相部の成分を加熱溶解し、これに調合粉末を
分散する。油相部を水相部中に混合して乳化
し、室温まで冷却してフアンデーシヨンクリー
ムを得た。
実施例 6
乳 液
A ステアリン酸 2.5
セタノール 1.5
ワセリン 5.0
流動パラフイン 10.0
酢酸トコフエロール 0.1
POE(10)オレエート 2.0
プロピルパラベン 0.1
香 料 0.2
B ポリエチレングリコール1500 3.0
トリエタノールアミン 1.0
アルブチン 1.0
ハイドロキノン−β−D−アラビノース 0.1
精製水 残余
(製法)実施例4に準じる。
実施例 7
吸水軟こう
ワセリン 40.0
ステアリルアルコール 15.0
モクロウ 15.0
POE(10)オレエート 0.25
ステアリン酸モノグリセライド 0.25
α−トコフエロール 1.0
アルブチン 1.0
精製水 残余
(製法)実施例4に準じる。
実施例 8
化粧水
エタノール 25.0
プロピレングリコール 10.0
POE(15)オレイルエーテル 1.0
酢酸トコフエロール 0.2
アルブチン 15.0
クエン酸 0.05
クエン酸ナトリウム 0.1
エチルパラベン 0.1
香 料 0.05
精製水 残余
(製法)実施例1に準じる。
実施例4〜実施例8は、いずれも経日安定性良
好で、使用性、安全性にも優れていた。[Table] In Table 1, the base is the following lotion, and the degree of discoloration is the result of the lotion after storage at 50°C for 1 month, as determined by the following criteria. (Base) Ethanol 13.0 1,3-butylene glycol 10.0 POE (polyoxyethylene, same below, 15 mol)
Oleyl ether 1.0 Ethylparaben 0.1 Fragrance 0.05 Purified water Residual (degree of discoloration) ◎ No discoloration ○ Slight discoloration △ Considerable discoloration × Example with significant discoloration 4 Night cream A Setanol 4.0 Vaseline 7.0 Squalane 21.0 Stearic acid monoglyceride 2.2 POE (20) Sorbitan monostearate 2.8 Isopropyl myristate 6.0 β-tocopherol 1.0 Ethylparaben 0.3 Fragrance 0.2 B Propylene glycol 10.0 1,3-butylene glycol 5.0 Arbutin 1.0 Purified water Remainder (manufacturing method) Components of the oil phase belonging to A The components of the aqueous phase belonging to B are separately heated and dissolved,
The oil phase was mixed into the water phase and emulsified, and the mixture was cooled to room temperature to obtain a cream. Example 5 Foundation A Setanol 3.5 Deodorized lanolin 4.0 Jojoba oil 5.0 Vaseline 2.0 Squalane 6.0 Stearic acid monoglyceride 2.5 Tocopheryl acetate 0.05 POE (60) Hydrogenated castor oil 1.5 POE (25) Cetyl ether 1.0 Fragrance 0.2 B Glycerin 3.0 Pro Pyrene glycol 8.0 Mixed powder 12.0 Arbutin 0.5 Purified water Heat and dissolve the remaining oil phase components belonging to (manufacturing method) A. Separately, the components of the aqueous phase belonging to B, excluding the blended powder, are heated and dissolved, and the blended powder is dispersed therein. The oil phase was mixed into the water phase, emulsified, and cooled to room temperature to obtain a foundation cream. Example 6 Emulsion A Stearic acid 2.5 Setanol 1.5 Vaseline 5.0 Liquid paraffin 10.0 Tocopheryl acetate 0.1 POE (10) oleate 2.0 Propyl paraben 0.1 Fragrance 0.2 B Polyethylene glycol 1500 3.0 Triethanolamine 1.0 Arbutin 1.0 Hydroquinone-β-D-arabi North 0.1 Purified water Residual (manufacturing method) Same as Example 4. Example 7 Water-absorbing ointment vaseline 40.0 Stearyl alcohol 15.0 Mokuro 15.0 POE (10) oleate 0.25 Stearic acid monoglyceride 0.25 α-tocopherol 1.0 Arbutin 1.0 Purified water Remaining material (manufacturing method) according to Example 4. Example 8 Toner lotion ethanol 25.0 Propylene glycol 10.0 POE (15) oleyl ether 1.0 Tocopherol acetate 0.2 Arbutin 15.0 Citric acid 0.05 Sodium citrate 0.1 Ethylparaben 0.1 Fragrance 0.05 Purified water Residue (manufacturing method) as in Example 1. Examples 4 to 8 all had good stability over time and were excellent in usability and safety.
Claims (1)
イドロキノン−β−D−グルコース1重量部に対
して0.001〜1重量部のビタミンE類を含有する
ことを特徴とする皮膚外用剤。1. A skin external preparation characterized by containing hydroquinone-β-D-glucose and 0.001 to 1 part by weight of vitamin E based on 1 part by weight of hydroquinone-β-D-glucose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5085385A JPS61210010A (en) | 1985-03-14 | 1985-03-14 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5085385A JPS61210010A (en) | 1985-03-14 | 1985-03-14 | External preparation for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61210010A JPS61210010A (en) | 1986-09-18 |
JPH0358326B2 true JPH0358326B2 (en) | 1991-09-05 |
Family
ID=12870277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5085385A Granted JPS61210010A (en) | 1985-03-14 | 1985-03-14 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61210010A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011503205A (en) * | 2007-11-14 | 2011-01-27 | オーエムピー インコーポレイテッド | Skin treatment composition |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU618517B2 (en) * | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
JP2001316268A (en) * | 2000-02-21 | 2001-11-13 | Ezaki Glico Co Ltd | Skin care preparation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5781410A (en) * | 1980-11-11 | 1982-05-21 | Tokitaka Mori | Remedy for skin pigmentation |
JPS6016906A (en) * | 1983-07-07 | 1985-01-28 | Pola Chem Ind Inc | External drug for skin |
-
1985
- 1985-03-14 JP JP5085385A patent/JPS61210010A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5781410A (en) * | 1980-11-11 | 1982-05-21 | Tokitaka Mori | Remedy for skin pigmentation |
JPS6016906A (en) * | 1983-07-07 | 1985-01-28 | Pola Chem Ind Inc | External drug for skin |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011503205A (en) * | 2007-11-14 | 2011-01-27 | オーエムピー インコーポレイテッド | Skin treatment composition |
Also Published As
Publication number | Publication date |
---|---|
JPS61210010A (en) | 1986-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940000671B1 (en) | Compositions for topical use having melanin synthesis-inhibiting activity | |
US5078989A (en) | Skin whitening cosmetics | |
KR102223207B1 (en) | Non-aqueous oil balm type cosmetics composition | |
JPH0725742A (en) | Fair-skinning cosmetic | |
JP2764510B2 (en) | Whitening cosmetics | |
JPH04342519A (en) | Skin cosmetic | |
JPS63208506A (en) | Cosmetic | |
JPS6281304A (en) | Emulsified cosmetic compounded with crude drug | |
JPH07101844A (en) | Multilayered emulsion | |
JPH0533683B2 (en) | ||
JP2004026740A (en) | Cosmetic | |
JPH108049A (en) | Antioxidant composition | |
JP2676049B2 (en) | Skin cosmetics | |
JPH0358326B2 (en) | ||
JPH10330243A (en) | Skin-whitening cosmetic | |
JP3434911B2 (en) | External preparation for skin | |
JP2663136B2 (en) | Whitening cosmetics | |
JPH0616532A (en) | Whitening and beautifying agent | |
JPH1036246A (en) | Suppressant for melanogenesis and preparation for external use for skin | |
JP3119622B2 (en) | Cosmetics | |
JPS6256411A (en) | Beautifying agent | |
JP2799569B2 (en) | Antioxidant composition | |
JPH10120546A (en) | Skin whitening preparation for external use | |
JP2906270B2 (en) | External preparation for skin | |
JP2522803B2 (en) | Cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |